Search Within

Lisa Bodei

  1. "Medical Physics"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (7)
  3. Book Section (1)
  4. Conference Paper (1)
  5. Editorial (1)
Groups
  1. Medical Physics (20)
  2. Molecular Imaging and Therapy Service (20)
  3. Radiology, Department of (20)
  4. Sloan Kettering Institute Postdocs (20)
  5. Department of Medicine (10)
  6. Solid Tumor Oncology Division (10)

More Groups

People
  1. Joseph O'Donoghue (13)
  2. Heiko Schoder (6)
  3. Jason Lewis (6)
  4. Simone Krebs (6)
  5. Daniel Lafontaine (5)
  6. Diane Reidy (5)

More People

Years
  1. 2024 (3)
  2. 2023 (7)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Journal of Nuclear Medicine (6)
  2. European Journal of Nuclear Medicine and Molecular Imaging (5)
  3. Clinical Cancer Research (1)
  4. Clinical Nuclear Medicine (1)
  5. International Journal of Radiation Oncology, Biology, Physics (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (6)
  2. Springer (6)
  3. Lippincott Williams & Wilkins (2)
  4. American Association for Cancer Research (1)
  5. American Society of Clinical Oncology (1)
  6. Elsevier Inc. (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • How can radiopharmaceutical therapies reach their full potential? Improving dose reporting and phase I clinical trial design
    Journal Article

    Kiess, A. P.; O'Donoghue, J.; Uribe, C.; Bodei, L.; Hobbs, R. F.; Hesterman, J.; Kesner, A. L.; Sgouros, G.; on behalf of the RPT-TEC group
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
    Editorial

    Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Dosimetry in radiopharmaceutical therapy
    Book Section

    Carter, L. M.; Kesner, A. L.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • A novel model-based planar reconstruction method for accurate activity distribution estimation for 225Ac-PSMA targeted alpha therapy
    Meeting Abstract

    Schmidtlein, C.; Ren, J.; Krol, A.; O'Donoghue, J.; Gifford, H.; Bodei, L.; Lafontaine, D.; Zechowy, D.; Xu, Y.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Index lesion dosimetry for (177)Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Meeting Abstract

    Grkovski, M.; O'Donoghue, J.; Imber, B.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M.; Humm, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Development of a semi-automatic platform for whole body tumor segmentation and radiomic feature extraction from 68Ga-DOTATATE PET/CT using TriDFusion (3DF)
    Meeting Abstract

    Krebs, S.; Lafontaine, D.; Bodei, L.; Mayerhoefer, M. E.; Humm, J.; Schòˆder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Lesion dosimetry for [(177)Lu]Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Journal Article

    Grkovski, M.; O'Donoghue, J. A.; Imber, B. S.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M. J.; Humm, J. L.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • A phase 1, open-label, dose-ascending study to evaluate the safety and tolerability of the therapeutic radiopharmaceutical (131)I-MIP-1095 for the treatment of metastatic castration-resistant prostate cancer
    Journal Article

    Laccetti, A. L.; Bodei, L.; O'Donoghue, J. A.; Weber, W. A.; Morris, M. J.
    Clinical Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy and (177)Lu-PSMA-617 for oligometastatic hormone sensitive prostate cancer
    Meeting Abstract

    Imber, B. S.; Bodei, L.; Humm, J.; Ionescu, A.; Wu, W.; Grkovski, M.; O'Donoghue, J.; Reddy, R. P.; Rimner, A.; Shasha, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save